US Stock MarketDetailed Quotes

OCUP Ocuphire Pharma

Watchlist

1.990
+0.140+7.57%

Close May 3 16:00 ET

1.940
-0.050-2.51%

Post 19:17 ET

50.96MMarket Cap-4326P/E (TTM)

Ocuphire Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

18.35%50.52M

203.53%42.36M

133.22%40M

101.28%39.01M

72.44%42.68M

-38.34%13.96M

-29.23%17.15M

82.89%19.38M

-Cash and cash equivalents

18.45%50.5M

205.67%42.35M

134.81%39.98M

102.58%38.99M

73.78%42.63M

-37.73%13.86M

-29.75%17.03M

81.62%19.25M

-Short-term investments

-69.39%15K

-89.11%11K

-82.54%22K

-83.70%22K

-77.63%49K

-73.63%101K

--126K

--135K

Receivables

-51.90%2.33M

--11.34M

--2.73M

--5.3M

--4.85M

----

-Accounts receivable

-28.66%926K

--10.13M

--135K

--2.83M

--1.3M

----

-Other receivables

-60.39%1.41M

--1.21M

--2.6M

--2.47M

--3.55M

----

Prepaid assets

-27.39%997K

-20.40%433K

-3.10%687K

-4.90%1.01M

10.46%1.37M

5.84%544K

-19.71%709K

-24.25%1.06M

Other current assets

27.50%102K

-16.39%51K

45.16%45K

136.36%78K

12.68%80K

32.61%61K

-57.53%31K

26.92%33K

Total current assets

10.13%53.95M

272.14%54.19M

142.92%43.46M

121.72%45.4M

87.92%48.99M

-37.22%14.56M

-29.12%17.89M

69.04%20.48M

Non current assets

Net PPE

--0

-57.14%3K

-50.00%4K

-44.44%5K

-40.00%6K

-36.36%7K

-33.33%8K

-30.77%9K

-Gross PPE

0.00%25K

-Accumulated depreciation

-31.58%-25K

-22.22%-22K

-23.53%-21K

-25.00%-20K

-26.67%-19K

-28.57%-18K

-30.77%-17K

-33.33%-16K

Total non current assets

--0

-57.14%3K

-50.00%4K

-44.44%5K

-40.00%6K

-36.36%7K

-33.33%8K

-30.77%9K

Total assets

10.12%53.95M

271.99%54.19M

142.83%43.47M

121.65%45.4M

87.87%48.99M

-37.22%14.57M

-29.12%17.9M

68.93%20.49M

Liabilities

Current liabilities

Payables

55.56%2.15M

29.50%1.9M

23.17%2.32M

60.61%2.54M

-12.63%1.38M

2.37%1.47M

26.07%1.89M

11.59%1.58M

-accounts payable

101.40%2.15M

28.75%1.89M

23.17%2.32M

40.66%2.22M

-32.51%1.07M

2.37%1.47M

26.07%1.89M

11.59%1.58M

-Total tax payable

--0

--11K

--0

--315K

----

Current accrued expenses

32.58%1.82M

15.70%1.42M

59.31%2.26M

14.02%1.62M

-21.00%1.37M

1.58%1.22M

17.87%1.42M

75.84%1.42M

Current debt and capital lease obligation

----

--215K

-Current debt

----

--215K

Other current liabilities

--74K

--93K

----

Current liabilities

46.82%4.04M

45.26%3.91M

74.36%5.76M

29.29%4.15M

-28.59%2.75M

2.01%2.69M

22.42%3.3M

39.09%3.21M

Non current liabilities

Derivative product liabilities

----

--0

----

--0

Total non current liabilities

--0

Total liabilities

46.82%4.04M

45.26%3.91M

74.36%5.76M

29.29%4.15M

-28.59%2.75M

2.01%2.69M

22.42%3.3M

39.09%3.21M

Shareholders'equity

Share capital

0.00%2K

100.00%2K

-common stock

0.00%2K

100.00%2K

-Preferred stock

--0

Retained earnings

-13.97%-81.47M

27.27%-76.67M

18.49%-82.23M

19.48%-77.27M

20.02%-71.48M

-26.93%-105.42M

-27.99%-100.89M

-33.86%-95.96M

Paid-in capital

11.60%131.37M

8.23%126.95M

3.85%119.93M

4.67%118.52M

5.49%117.72M

13.20%117.3M

13.92%115.48M

38.93%113.23M

Total stockholders'equity

7.93%49.91M

323.36%50.28M

158.34%37.7M

138.83%41.25M

108.08%46.24M

-42.25%11.88M

-35.29%14.6M

75.96%17.27M

Total equity

7.93%49.91M

323.36%50.28M

158.34%37.7M

138.83%41.25M

108.08%46.24M

-42.25%11.88M

-35.29%14.6M

75.96%17.27M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	18.35%50.52M	18.35%50.52M	203.53%42.36M	133.22%40M	101.28%39.01M	72.44%42.68M	72.44%42.68M	-38.34%13.96M	-29.23%17.15M	82.89%19.38M
-Cash and cash equivalents	18.45%50.5M	18.45%50.5M	205.67%42.35M	134.81%39.98M	102.58%38.99M	73.78%42.63M	73.78%42.63M	-37.73%13.86M	-29.75%17.03M	81.62%19.25M
-Short-term investments	-69.39%15K	-69.39%15K	-89.11%11K	-82.54%22K	-83.70%22K	-77.63%49K	-77.63%49K	-73.63%101K	--126K	--135K
Receivables	-51.90%2.33M	-51.90%2.33M	--11.34M	--2.73M	--5.3M	--4.85M	--4.85M	----	----	----
-Accounts receivable	-28.66%926K	-28.66%926K	--10.13M	--135K	--2.83M	--1.3M	--1.3M	----	----	----
-Other receivables	-60.39%1.41M	-60.39%1.41M	--1.21M	--2.6M	--2.47M	--3.55M	--3.55M	----	----	----
Prepaid assets	-27.39%997K	-27.39%997K	-20.40%433K	-3.10%687K	-4.90%1.01M	10.46%1.37M	10.46%1.37M	5.84%544K	-19.71%709K	-24.25%1.06M
Other current assets	27.50%102K	27.50%102K	-16.39%51K	45.16%45K	136.36%78K	12.68%80K	12.68%80K	32.61%61K	-57.53%31K	26.92%33K
Total current assets	10.13%53.95M	10.13%53.95M	272.14%54.19M	142.92%43.46M	121.72%45.4M	87.92%48.99M	87.92%48.99M	-37.22%14.56M	-29.12%17.89M	69.04%20.48M
Non current assets
Net PPE	--0	--0	-57.14%3K	-50.00%4K	-44.44%5K	-40.00%6K	-40.00%6K	-36.36%7K	-33.33%8K	-30.77%9K
-Gross PPE	0.00%25K	0.00%25K	0.00%25K	0.00%25K	0.00%25K	0.00%25K	0.00%25K	0.00%25K	0.00%25K	0.00%25K
-Accumulated depreciation	-31.58%-25K	-31.58%-25K	-22.22%-22K	-23.53%-21K	-25.00%-20K	-26.67%-19K	-26.67%-19K	-28.57%-18K	-30.77%-17K	-33.33%-16K
Total non current assets	--0	--0	-57.14%3K	-50.00%4K	-44.44%5K	-40.00%6K	-40.00%6K	-36.36%7K	-33.33%8K	-30.77%9K
Total assets	10.12%53.95M	10.12%53.95M	271.99%54.19M	142.83%43.47M	121.65%45.4M	87.87%48.99M	87.87%48.99M	-37.22%14.57M	-29.12%17.9M	68.93%20.49M
Liabilities
Current liabilities
Payables	55.56%2.15M	55.56%2.15M	29.50%1.9M	23.17%2.32M	60.61%2.54M	-12.63%1.38M	-12.63%1.38M	2.37%1.47M	26.07%1.89M	11.59%1.58M
-accounts payable	101.40%2.15M	101.40%2.15M	28.75%1.89M	23.17%2.32M	40.66%2.22M	-32.51%1.07M	-32.51%1.07M	2.37%1.47M	26.07%1.89M	11.59%1.58M
-Total tax payable	--0	--0	--11K	--0	--315K	--315K	--315K	----	----	----
Current accrued expenses	32.58%1.82M	32.58%1.82M	15.70%1.42M	59.31%2.26M	14.02%1.62M	-21.00%1.37M	-21.00%1.37M	1.58%1.22M	17.87%1.42M	75.84%1.42M
Current debt and capital lease obligation	----	----	----	----	----	----	----	----	----	--215K
-Current debt	----	----	----	----	----	----	----	----	----	--215K
Other current liabilities	--74K	--74K	--93K	----	----	----	----	----	----	----
Current liabilities	46.82%4.04M	46.82%4.04M	45.26%3.91M	74.36%5.76M	29.29%4.15M	-28.59%2.75M	-28.59%2.75M	2.01%2.69M	22.42%3.3M	39.09%3.21M
Non current liabilities
Derivative product liabilities	----	----	----	----	--0	----	----	--0	--0	--0
Total non current liabilities	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total liabilities	46.82%4.04M	46.82%4.04M	45.26%3.91M	74.36%5.76M	29.29%4.15M	-28.59%2.75M	-28.59%2.75M	2.01%2.69M	22.42%3.3M	39.09%3.21M
Shareholders'equity
Share capital	0.00%2K	0.00%2K	0.00%2K	0.00%2K	0.00%2K	0.00%2K	0.00%2K	0.00%2K	0.00%2K	100.00%2K
-common stock	0.00%2K	0.00%2K	0.00%2K	0.00%2K	0.00%2K	0.00%2K	0.00%2K	0.00%2K	0.00%2K	100.00%2K
-Preferred stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Retained earnings	-13.97%-81.47M	-13.97%-81.47M	27.27%-76.67M	18.49%-82.23M	19.48%-77.27M	20.02%-71.48M	20.02%-71.48M	-26.93%-105.42M	-27.99%-100.89M	-33.86%-95.96M
Paid-in capital	11.60%131.37M	11.60%131.37M	8.23%126.95M	3.85%119.93M	4.67%118.52M	5.49%117.72M	5.49%117.72M	13.20%117.3M	13.92%115.48M	38.93%113.23M
Total stockholders'equity	7.93%49.91M	7.93%49.91M	323.36%50.28M	158.34%37.7M	138.83%41.25M	108.08%46.24M	108.08%46.24M	-42.25%11.88M	-35.29%14.6M	75.96%17.27M
Total equity	7.93%49.91M	7.93%49.91M	323.36%50.28M	158.34%37.7M	138.83%41.25M	108.08%46.24M	108.08%46.24M	-42.25%11.88M	-35.29%14.6M	75.96%17.27M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall